123 related articles for article (PubMed ID: 14674144)
1. [Thymidine phosphorylase activity and neo-angiogenesis in ovarian cancer].
Wójcik-Krowiranda K; Miszczak-Zaborska E; Gottwald L; Bieńkiewicz A
Ginekol Pol; 2003 Sep; 74(9):911-7. PubMed ID: 14674144
[TBL] [Abstract][Full Text] [Related]
2. The activity of thymidine phosphorylase as a new ovarian tumor marker.
Miszczak-Zaborska E; Wójcik-Krowiranda K; Kubiak R; Bieńkiewicz A; Bartkowiak J
Gynecol Oncol; 2004 Jul; 94(1):86-92. PubMed ID: 15262124
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer.
Seki N; Kodama J; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
Int J Oncol; 1999 Oct; 15(4):781-6. PubMed ID: 10493962
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
5. The cytosol activity of thymidine phosphorylase in endometrial cancer.
Miszczak-Zaborska E; Kubiak R; Bieńkiewicz A; Bartkowiak J
J Exp Clin Cancer Res; 2008 Nov; 27(1):64. PubMed ID: 18986516
[TBL] [Abstract][Full Text] [Related]
6. [The thymidine phosphorylase as the platelet-derived endothelial cell growth factor of endometrial cancer].
Kubiak R; Miszczak-Zaborska E; Smolarek M; Wójcik-Krowiranda K; Bartkowiak J
Ginekol Pol; 2009 Aug; 80(8):596-601. PubMed ID: 19824458
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.
Kodama J; Yoshinouchi M; Seki N; Hongo A; Miyagi Y; Kudo T
Int J Oncol; 1999 Jul; 15(1):149-54. PubMed ID: 10375608
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis.
Hata K; Nagami H; Iida K; Miyazaki K; Collins WP
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):201-6. PubMed ID: 9793193
[TBL] [Abstract][Full Text] [Related]
10. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
12. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
13. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity.
Hata K; Fujiwaki R; Maede Y; Nakayama K; Fukumoto M; Miyazaki K
Gynecol Oncol; 2000 Apr; 77(1):26-34. PubMed ID: 10739687
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines.
Zhang L; Mackenzie IZ; Rees MC; Bicknell R
Endocrinology; 1997 Nov; 138(11):4921-30. PubMed ID: 9348223
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K
Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer.
Fujiwaki R; Hata K; Iida K; Koike M; Miyazaki K
Gynecol Oncol; 1998 Mar; 68(3):247-52. PubMed ID: 9570975
[TBL] [Abstract][Full Text] [Related]
18. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer.
Toi M; Hoshina S; Taniguchi T; Yamamoto Y; Ishitsuka H; Tominaga T
Int J Cancer; 1995 Apr; 64(2):79-82. PubMed ID: 7542228
[TBL] [Abstract][Full Text] [Related]
19. [Influence of the selected pyrimidine compounds on the activity of thymidine phosphorylase from normal and tumor endometrial cells].
Miszczak-Zaborska E; Smolarek M; Dramiński M; Kubiak R; Józwiak B; Bartkowiak J
Ginekol Pol; 2009 Aug; 80(8):590-5. PubMed ID: 19824457
[TBL] [Abstract][Full Text] [Related]
20. Thymidine phosphorylase activity in normal, hyperplastic and neoplastic endometrium--correlation with intratumoral angiogenesis.
Sivridis E
Adv Exp Med Biol; 2000; 476():297-303. PubMed ID: 10949674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
